Exploratory study of pre-surgical medications with dienogest or leuprorelin in laparoscopic cystectomy of endometrial cysts

Aim The aim of this study was to compare the effects of pre‐surgical medication with dienogest or leuprorelin on post‐surgical ovarian function. Material and Methods We conducted an exploratory study in two centers in Japan that comprised 30 patients with ovarian endometrial cysts for whom surgical...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of obstetrics and gynaecology research 2015-08, Vol.41 (8), p.1234-1239
Hauptverfasser: Takenaka, Motoki, Yano, Ryuichiro, Hiraku, Yuka, Shibata, Mayuko, Hatano, Kayoko, Yamamoto, Shiori, Sato, Kazuki, Yamamoto, Kazushige, Morishige, Ken-ichiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1239
container_issue 8
container_start_page 1234
container_title The journal of obstetrics and gynaecology research
container_volume 41
creator Takenaka, Motoki
Yano, Ryuichiro
Hiraku, Yuka
Shibata, Mayuko
Hatano, Kayoko
Yamamoto, Shiori
Sato, Kazuki
Yamamoto, Kazushige
Morishige, Ken-ichiro
description Aim The aim of this study was to compare the effects of pre‐surgical medication with dienogest or leuprorelin on post‐surgical ovarian function. Material and Methods We conducted an exploratory study in two centers in Japan that comprised 30 patients with ovarian endometrial cysts for whom surgical excision was planned. Patients were enrolled and divided into pre‐surgical medication groups with dienogest or leuprorelin for 12 weeks. Thereafter, patients were treated by laparoscopic cystectomy. The primary outcome was ovarian function post‐surgery, as assessed by serum anti‐Müllerian hormone (AMH) level, antral follicle count (AFC) and resumption of menses. Secondary outcome was the effect of pre‐surgical medication, as assessed by the size of endometrial cysts and visual analog scale (VAS) score. Serum AMH, AFC, size of endometrial cysts, and VAS scores were measured at baseline (before medication), after medication (1 day before surgery), and at 4 and 12 weeks post‐surgery. Results Serum AMH levels did not change after pre‐surgical medication with either dienogest or leuprorelin. Although AMH decreased after surgery, it recovered by 12 weeks post‐surgery in both groups with no statistically significant difference. Mean AFC did not change after surgery in either group. Menses returned by 12 weeks post‐surgery in all patients except for those who were pregnant. The rate of reduction of endometrial cyst volume did not differ between the groups. Both dienogest and leuprorelin were associated with substantial reductions in VAS scores. Conclusion There were no statistically significant differences between pre‐surgical medication with dienogest and leuprorelin in post‐surgical ovarian function. Both medications were effective in reducing endometrial cyst volume and VAS score.
doi_str_mv 10.1111/jog.12701
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1700333360</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1700333360</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4571-c7a47e3c6372f2dc619f69e64943e69ea6e569e416029649bed43e5b57e67b163</originalsourceid><addsrcrecordid>eNp1kEFP3DAQha2qVaG0h_6BysdyCNixY2-O7You0FU5lKpHy-tMtqZOHOxEEPHnGVjghmXpjTxvnsYfIZ85O-J4jq_i9oiXmvE3ZJ9LqQumK_UWayF5sWBa7ZEPOV8xxnXNF-_JXlkthBBysU_uTm6HEJMdY5ppHqdmprGlQ4IiT2nrnQ20gwZ19LHP9MaP_2jjoY9byCONiQaYhhQTBN9TvMEONsXs4uAddXMewY2xewyFvokdjMlj5kMnfyTvWhsyfHrSA_Lnx8nl8rRYX6zOlt_WhZOV5oXTVmoQTgldtmXjFK9bVYOStRSAhVVQoUiuWFnj6wYabFSbSoPSG67EAfm6y8VFryfc23Q-OwjB9hCnbLhmDHEIxdB6uLM6_ERO0Joh-c6m2XBmHlgbZG0eWaP3y1PstEFGL85nuGg43hlufID59SRzfrF6jix2Ex7B3b5M2PTfKC10Zf7-WplLppj--X1tfot7tg6aLA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1700333360</pqid></control><display><type>article</type><title>Exploratory study of pre-surgical medications with dienogest or leuprorelin in laparoscopic cystectomy of endometrial cysts</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Takenaka, Motoki ; Yano, Ryuichiro ; Hiraku, Yuka ; Shibata, Mayuko ; Hatano, Kayoko ; Yamamoto, Shiori ; Sato, Kazuki ; Yamamoto, Kazushige ; Morishige, Ken-ichiro</creator><creatorcontrib>Takenaka, Motoki ; Yano, Ryuichiro ; Hiraku, Yuka ; Shibata, Mayuko ; Hatano, Kayoko ; Yamamoto, Shiori ; Sato, Kazuki ; Yamamoto, Kazushige ; Morishige, Ken-ichiro</creatorcontrib><description>Aim The aim of this study was to compare the effects of pre‐surgical medication with dienogest or leuprorelin on post‐surgical ovarian function. Material and Methods We conducted an exploratory study in two centers in Japan that comprised 30 patients with ovarian endometrial cysts for whom surgical excision was planned. Patients were enrolled and divided into pre‐surgical medication groups with dienogest or leuprorelin for 12 weeks. Thereafter, patients were treated by laparoscopic cystectomy. The primary outcome was ovarian function post‐surgery, as assessed by serum anti‐Müllerian hormone (AMH) level, antral follicle count (AFC) and resumption of menses. Secondary outcome was the effect of pre‐surgical medication, as assessed by the size of endometrial cysts and visual analog scale (VAS) score. Serum AMH, AFC, size of endometrial cysts, and VAS scores were measured at baseline (before medication), after medication (1 day before surgery), and at 4 and 12 weeks post‐surgery. Results Serum AMH levels did not change after pre‐surgical medication with either dienogest or leuprorelin. Although AMH decreased after surgery, it recovered by 12 weeks post‐surgery in both groups with no statistically significant difference. Mean AFC did not change after surgery in either group. Menses returned by 12 weeks post‐surgery in all patients except for those who were pregnant. The rate of reduction of endometrial cyst volume did not differ between the groups. Both dienogest and leuprorelin were associated with substantial reductions in VAS scores. Conclusion There were no statistically significant differences between pre‐surgical medication with dienogest and leuprorelin in post‐surgical ovarian function. Both medications were effective in reducing endometrial cyst volume and VAS score.</description><identifier>ISSN: 1341-8076</identifier><identifier>EISSN: 1447-0756</identifier><identifier>DOI: 10.1111/jog.12701</identifier><identifier>PMID: 25833348</identifier><language>eng</language><publisher>Australia: Blackwell Publishing Ltd</publisher><subject>Adult ; Anti-Mullerian Hormone - blood ; endometrial cyst ; Endometriosis - drug therapy ; Endometriosis - physiopathology ; Endometriosis - surgery ; Female ; Humans ; laparoscopic cystectomy ; Laparoscopy - methods ; Leuprolide - therapeutic use ; Nandrolone - analogs &amp; derivatives ; Nandrolone - therapeutic use ; Ovarian Cysts - blood ; Ovarian Cysts - drug therapy ; Ovarian Cysts - physiopathology ; Ovarian Cysts - surgery ; ovarian function ; Ovary - pathology ; Ovary - physiopathology ; pre-surgical medication ; Visual Analog Scale</subject><ispartof>The journal of obstetrics and gynaecology research, 2015-08, Vol.41 (8), p.1234-1239</ispartof><rights>2015 The Authors. Journal of Obstetrics and Gynaecology Research © 2015 Japan Society of Obstetrics and Gynecology</rights><rights>2015 The Authors. Journal of Obstetrics and Gynaecology Research © 2015 Japan Society of Obstetrics and Gynecology.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4571-c7a47e3c6372f2dc619f69e64943e69ea6e569e416029649bed43e5b57e67b163</citedby><cites>FETCH-LOGICAL-c4571-c7a47e3c6372f2dc619f69e64943e69ea6e569e416029649bed43e5b57e67b163</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjog.12701$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjog.12701$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25833348$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Takenaka, Motoki</creatorcontrib><creatorcontrib>Yano, Ryuichiro</creatorcontrib><creatorcontrib>Hiraku, Yuka</creatorcontrib><creatorcontrib>Shibata, Mayuko</creatorcontrib><creatorcontrib>Hatano, Kayoko</creatorcontrib><creatorcontrib>Yamamoto, Shiori</creatorcontrib><creatorcontrib>Sato, Kazuki</creatorcontrib><creatorcontrib>Yamamoto, Kazushige</creatorcontrib><creatorcontrib>Morishige, Ken-ichiro</creatorcontrib><title>Exploratory study of pre-surgical medications with dienogest or leuprorelin in laparoscopic cystectomy of endometrial cysts</title><title>The journal of obstetrics and gynaecology research</title><addtitle>J. Obstet. Gynaecol. Res</addtitle><description>Aim The aim of this study was to compare the effects of pre‐surgical medication with dienogest or leuprorelin on post‐surgical ovarian function. Material and Methods We conducted an exploratory study in two centers in Japan that comprised 30 patients with ovarian endometrial cysts for whom surgical excision was planned. Patients were enrolled and divided into pre‐surgical medication groups with dienogest or leuprorelin for 12 weeks. Thereafter, patients were treated by laparoscopic cystectomy. The primary outcome was ovarian function post‐surgery, as assessed by serum anti‐Müllerian hormone (AMH) level, antral follicle count (AFC) and resumption of menses. Secondary outcome was the effect of pre‐surgical medication, as assessed by the size of endometrial cysts and visual analog scale (VAS) score. Serum AMH, AFC, size of endometrial cysts, and VAS scores were measured at baseline (before medication), after medication (1 day before surgery), and at 4 and 12 weeks post‐surgery. Results Serum AMH levels did not change after pre‐surgical medication with either dienogest or leuprorelin. Although AMH decreased after surgery, it recovered by 12 weeks post‐surgery in both groups with no statistically significant difference. Mean AFC did not change after surgery in either group. Menses returned by 12 weeks post‐surgery in all patients except for those who were pregnant. The rate of reduction of endometrial cyst volume did not differ between the groups. Both dienogest and leuprorelin were associated with substantial reductions in VAS scores. Conclusion There were no statistically significant differences between pre‐surgical medication with dienogest and leuprorelin in post‐surgical ovarian function. Both medications were effective in reducing endometrial cyst volume and VAS score.</description><subject>Adult</subject><subject>Anti-Mullerian Hormone - blood</subject><subject>endometrial cyst</subject><subject>Endometriosis - drug therapy</subject><subject>Endometriosis - physiopathology</subject><subject>Endometriosis - surgery</subject><subject>Female</subject><subject>Humans</subject><subject>laparoscopic cystectomy</subject><subject>Laparoscopy - methods</subject><subject>Leuprolide - therapeutic use</subject><subject>Nandrolone - analogs &amp; derivatives</subject><subject>Nandrolone - therapeutic use</subject><subject>Ovarian Cysts - blood</subject><subject>Ovarian Cysts - drug therapy</subject><subject>Ovarian Cysts - physiopathology</subject><subject>Ovarian Cysts - surgery</subject><subject>ovarian function</subject><subject>Ovary - pathology</subject><subject>Ovary - physiopathology</subject><subject>pre-surgical medication</subject><subject>Visual Analog Scale</subject><issn>1341-8076</issn><issn>1447-0756</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEFP3DAQha2qVaG0h_6BysdyCNixY2-O7You0FU5lKpHy-tMtqZOHOxEEPHnGVjghmXpjTxvnsYfIZ85O-J4jq_i9oiXmvE3ZJ9LqQumK_UWayF5sWBa7ZEPOV8xxnXNF-_JXlkthBBysU_uTm6HEJMdY5ppHqdmprGlQ4IiT2nrnQ20gwZ19LHP9MaP_2jjoY9byCONiQaYhhQTBN9TvMEONsXs4uAddXMewY2xewyFvokdjMlj5kMnfyTvWhsyfHrSA_Lnx8nl8rRYX6zOlt_WhZOV5oXTVmoQTgldtmXjFK9bVYOStRSAhVVQoUiuWFnj6wYabFSbSoPSG67EAfm6y8VFryfc23Q-OwjB9hCnbLhmDHEIxdB6uLM6_ERO0Joh-c6m2XBmHlgbZG0eWaP3y1PstEFGL85nuGg43hlufID59SRzfrF6jix2Ex7B3b5M2PTfKC10Zf7-WplLppj--X1tfot7tg6aLA</recordid><startdate>201508</startdate><enddate>201508</enddate><creator>Takenaka, Motoki</creator><creator>Yano, Ryuichiro</creator><creator>Hiraku, Yuka</creator><creator>Shibata, Mayuko</creator><creator>Hatano, Kayoko</creator><creator>Yamamoto, Shiori</creator><creator>Sato, Kazuki</creator><creator>Yamamoto, Kazushige</creator><creator>Morishige, Ken-ichiro</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201508</creationdate><title>Exploratory study of pre-surgical medications with dienogest or leuprorelin in laparoscopic cystectomy of endometrial cysts</title><author>Takenaka, Motoki ; Yano, Ryuichiro ; Hiraku, Yuka ; Shibata, Mayuko ; Hatano, Kayoko ; Yamamoto, Shiori ; Sato, Kazuki ; Yamamoto, Kazushige ; Morishige, Ken-ichiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4571-c7a47e3c6372f2dc619f69e64943e69ea6e569e416029649bed43e5b57e67b163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Anti-Mullerian Hormone - blood</topic><topic>endometrial cyst</topic><topic>Endometriosis - drug therapy</topic><topic>Endometriosis - physiopathology</topic><topic>Endometriosis - surgery</topic><topic>Female</topic><topic>Humans</topic><topic>laparoscopic cystectomy</topic><topic>Laparoscopy - methods</topic><topic>Leuprolide - therapeutic use</topic><topic>Nandrolone - analogs &amp; derivatives</topic><topic>Nandrolone - therapeutic use</topic><topic>Ovarian Cysts - blood</topic><topic>Ovarian Cysts - drug therapy</topic><topic>Ovarian Cysts - physiopathology</topic><topic>Ovarian Cysts - surgery</topic><topic>ovarian function</topic><topic>Ovary - pathology</topic><topic>Ovary - physiopathology</topic><topic>pre-surgical medication</topic><topic>Visual Analog Scale</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takenaka, Motoki</creatorcontrib><creatorcontrib>Yano, Ryuichiro</creatorcontrib><creatorcontrib>Hiraku, Yuka</creatorcontrib><creatorcontrib>Shibata, Mayuko</creatorcontrib><creatorcontrib>Hatano, Kayoko</creatorcontrib><creatorcontrib>Yamamoto, Shiori</creatorcontrib><creatorcontrib>Sato, Kazuki</creatorcontrib><creatorcontrib>Yamamoto, Kazushige</creatorcontrib><creatorcontrib>Morishige, Ken-ichiro</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of obstetrics and gynaecology research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takenaka, Motoki</au><au>Yano, Ryuichiro</au><au>Hiraku, Yuka</au><au>Shibata, Mayuko</au><au>Hatano, Kayoko</au><au>Yamamoto, Shiori</au><au>Sato, Kazuki</au><au>Yamamoto, Kazushige</au><au>Morishige, Ken-ichiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exploratory study of pre-surgical medications with dienogest or leuprorelin in laparoscopic cystectomy of endometrial cysts</atitle><jtitle>The journal of obstetrics and gynaecology research</jtitle><addtitle>J. Obstet. Gynaecol. Res</addtitle><date>2015-08</date><risdate>2015</risdate><volume>41</volume><issue>8</issue><spage>1234</spage><epage>1239</epage><pages>1234-1239</pages><issn>1341-8076</issn><eissn>1447-0756</eissn><abstract>Aim The aim of this study was to compare the effects of pre‐surgical medication with dienogest or leuprorelin on post‐surgical ovarian function. Material and Methods We conducted an exploratory study in two centers in Japan that comprised 30 patients with ovarian endometrial cysts for whom surgical excision was planned. Patients were enrolled and divided into pre‐surgical medication groups with dienogest or leuprorelin for 12 weeks. Thereafter, patients were treated by laparoscopic cystectomy. The primary outcome was ovarian function post‐surgery, as assessed by serum anti‐Müllerian hormone (AMH) level, antral follicle count (AFC) and resumption of menses. Secondary outcome was the effect of pre‐surgical medication, as assessed by the size of endometrial cysts and visual analog scale (VAS) score. Serum AMH, AFC, size of endometrial cysts, and VAS scores were measured at baseline (before medication), after medication (1 day before surgery), and at 4 and 12 weeks post‐surgery. Results Serum AMH levels did not change after pre‐surgical medication with either dienogest or leuprorelin. Although AMH decreased after surgery, it recovered by 12 weeks post‐surgery in both groups with no statistically significant difference. Mean AFC did not change after surgery in either group. Menses returned by 12 weeks post‐surgery in all patients except for those who were pregnant. The rate of reduction of endometrial cyst volume did not differ between the groups. Both dienogest and leuprorelin were associated with substantial reductions in VAS scores. Conclusion There were no statistically significant differences between pre‐surgical medication with dienogest and leuprorelin in post‐surgical ovarian function. Both medications were effective in reducing endometrial cyst volume and VAS score.</abstract><cop>Australia</cop><pub>Blackwell Publishing Ltd</pub><pmid>25833348</pmid><doi>10.1111/jog.12701</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1341-8076
ispartof The journal of obstetrics and gynaecology research, 2015-08, Vol.41 (8), p.1234-1239
issn 1341-8076
1447-0756
language eng
recordid cdi_proquest_miscellaneous_1700333360
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adult
Anti-Mullerian Hormone - blood
endometrial cyst
Endometriosis - drug therapy
Endometriosis - physiopathology
Endometriosis - surgery
Female
Humans
laparoscopic cystectomy
Laparoscopy - methods
Leuprolide - therapeutic use
Nandrolone - analogs & derivatives
Nandrolone - therapeutic use
Ovarian Cysts - blood
Ovarian Cysts - drug therapy
Ovarian Cysts - physiopathology
Ovarian Cysts - surgery
ovarian function
Ovary - pathology
Ovary - physiopathology
pre-surgical medication
Visual Analog Scale
title Exploratory study of pre-surgical medications with dienogest or leuprorelin in laparoscopic cystectomy of endometrial cysts
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T03%3A21%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exploratory%20study%20of%20pre-surgical%20medications%20with%20dienogest%20or%20leuprorelin%20in%20laparoscopic%20cystectomy%20of%20endometrial%20cysts&rft.jtitle=The%20journal%20of%20obstetrics%20and%20gynaecology%20research&rft.au=Takenaka,%20Motoki&rft.date=2015-08&rft.volume=41&rft.issue=8&rft.spage=1234&rft.epage=1239&rft.pages=1234-1239&rft.issn=1341-8076&rft.eissn=1447-0756&rft_id=info:doi/10.1111/jog.12701&rft_dat=%3Cproquest_cross%3E1700333360%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1700333360&rft_id=info:pmid/25833348&rfr_iscdi=true